Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila Belkhir

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|April 21, 2021
Delayed Large Local Reactions to mRNA VaccinesMarie Baeck, Liliane Marot, Leila Belkhir
European Heart Journal. Case Reports|August 12, 2024
Valve-in-valve transcatheter aortic valve implantation (TAVI): a new valuable approach to bioprosthetic infective endocarditis?Joelle Kefer, David Vancraeynest, Véronique Roelants, et al.
Endoscopy|September 8, 2021
Actinomycosis associated with a permanently implanted duodenal over-the-scope clipCarina Leal, Helene Dano, Leila Belkhir, et al.
The Lancet. Infectious Diseases|April 30, 2019
Mimicking oesophageal cancer: oesophageal actinomycosisYannick Deswysen, Laura Van Ginderachter, Helene Dano, et al.
Acta Clinica Belgica|March 3, 2018
Aerococcus urinae: an underestimated cause of spine infection? Case report and review of the literatureElodie Degroote, Halil Yildiz, Frederic Lecouvet, et al.
Journal of Perinatal Medicine|September 29, 2020
Testing of patients and coronavirus disease 2019 (COVID-19) infection before scheduled deliveriesJean Cyr Yombi, Julien De Greef, Pierre Bernard, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 19, 2018
Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?Gabriel Stillemans, Leila Belkhir, Dennis A Hesselink, et al.
European Journal of Clinical Pharmacology|November 11, 2020
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic modelGabriel Stillemans, Leila Belkhir, Bernard Vandercam, et al.
Clinical Pharmacokinetics|July 23, 2020
Exploration of Reduced Doses and Short-Cycle Therapy for Darunavir/Cobicistat in Patients with HIV Using Population Pharmacokinetic Modeling and SimulationsGabriel Stillemans, Leila Belkhir, Bernard Vandercam, et al.
AIDS Patient Care and Stds|May 21, 2013
Adherence to screening guidelines for hepatitis C among HIV-positive patientsSylvie Jonckheere, Anne Vincent, Leila Belkhir, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|April 21, 2021
Delayed Large Local Reactions to mRNA VaccinesMarie Baeck, Liliane Marot, Leila Belkhir
European Heart Journal. Case Reports|August 12, 2024
Valve-in-valve transcatheter aortic valve implantation (TAVI): a new valuable approach to bioprosthetic infective endocarditis?Joelle Kefer, David Vancraeynest, Véronique Roelants, et al.
Endoscopy|September 8, 2021
Actinomycosis associated with a permanently implanted duodenal over-the-scope clipCarina Leal, Helene Dano, Leila Belkhir, et al.
The Lancet. Infectious Diseases|April 30, 2019
Mimicking oesophageal cancer: oesophageal actinomycosisYannick Deswysen, Laura Van Ginderachter, Helene Dano, et al.
Acta Clinica Belgica|March 3, 2018
Aerococcus urinae: an underestimated cause of spine infection? Case report and review of the literatureElodie Degroote, Halil Yildiz, Frederic Lecouvet, et al.
Journal of Perinatal Medicine|September 29, 2020
Testing of patients and coronavirus disease 2019 (COVID-19) infection before scheduled deliveriesJean Cyr Yombi, Julien De Greef, Pierre Bernard, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 19, 2018
Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?Gabriel Stillemans, Leila Belkhir, Dennis A Hesselink, et al.
European Journal of Clinical Pharmacology|November 11, 2020
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic modelGabriel Stillemans, Leila Belkhir, Bernard Vandercam, et al.
Clinical Pharmacokinetics|July 23, 2020
Exploration of Reduced Doses and Short-Cycle Therapy for Darunavir/Cobicistat in Patients with HIV Using Population Pharmacokinetic Modeling and SimulationsGabriel Stillemans, Leila Belkhir, Bernard Vandercam, et al.
AIDS Patient Care and Stds|May 21, 2013
Adherence to screening guidelines for hepatitis C among HIV-positive patientsSylvie Jonckheere, Anne Vincent, Leila Belkhir, et al.
Pageof 6